Berenberg Bank Boosts Diploma (LON:DPLM) Price Target to GBX 7,500

Diploma (LON:DPLM) had its price objective increased by Berenberg Bank from GBX 6,600 to GBX 7,500 in a research report issued to clients and investors on Thursday, Marketbeat.com reports. The firm presently has a “buy” rating on the stock. Berenberg Bank’s target price would indicate a potential upside of 31.28% from the company’s previous close.

DPLM has been the topic of a number of other reports. Peel Hunt restated a “buy” rating and issued a GBX 6,150 price objective on shares of Diploma in a research note on Friday, December 19th. Shore Capital Group reiterated a “hold” rating on shares of Diploma in a research report on Wednesday. Stifel Nicolaus lifted their target price on shares of Diploma from GBX 6,200 to GBX 6,800 and gave the stock a “buy” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Diploma from GBX 6,200 to GBX 6,400 and gave the company a “buy” rating in a research report on Thursday. Finally, Royal Bank Of Canada upped their price target on shares of Diploma from GBX 6,200 to GBX 6,600 and gave the company an “outperform” rating in a research note on Thursday. Five research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of GBX 6,023.75.

Diploma Stock Down 1.8%

Shares of LON DPLM opened at GBX 5,712.95 on Thursday. The company has a debt-to-equity ratio of 46.97, a current ratio of 2.04 and a quick ratio of 0.80. The stock has a market capitalization of £7.66 billion, a PE ratio of 41.61, a P/E/G ratio of 2.82 and a beta of 1.03. Diploma has a one year low of GBX 3,532 and a one year high of GBX 6,019.52. The business’s fifty day moving average price is GBX 5,457.51 and its 200-day moving average price is GBX 5,425.55.

Insiders Place Their Bets

In related news, insider Katie Bickerstaffe purchased 352 shares of the firm’s stock in a transaction dated Wednesday, January 14th. The shares were purchased at an average cost of GBX 5,645 per share, for a total transaction of £19,870.40. Also, insider Johnny Thomson sold 30,000 shares of the company’s stock in a transaction dated Friday, January 16th. The shares were sold at an average price of GBX 5,668, for a total value of £1,700,400. 1.14% of the stock is owned by corporate insiders.

Key Headlines Impacting Diploma

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Surprise profit upgrade forced a re‑rating of consensus and sparked a ~17% share jump as investors digested stronger-than-expected guidance. Diploma shares surge 17% as surprise profit upgrade exposes the bearish consensus
• Positive Sentiment: Guidance upgrade lifted Diploma’s earnings forecasts (~15%) and prompted price-target increases (headline 6,600p), reinforcing the bullish re-rate. Diploma price target lifted to 6,600p after guidance upgrade drives 15% earnings forecast rise
• Positive Sentiment: Berenberg raised its price target sharply to GBX 7,500 and moved to a “buy” rating, signaling confidence in the upgraded outlook. Broker ratings
• Positive Sentiment: Stifel increased its target to GBX 6,800 and upgraded to “buy”, adding to the cluster of upward revisions from brokers. Broker ratings
• Positive Sentiment: Deutsche Bank raised its target to GBX 6,400 and now carries a “buy” stance, supporting the upward momentum. Broker ratings
• Positive Sentiment: Royal Bank of Canada lifted its target to GBX 6,600 and set an “outperform” rating — another well‑known house backing the upgraded story. RBC note
• Negative Sentiment: Shore Capital reaffirmed a “hold” rating on 20 March, which may have damped some of the rally and encouraged profit‑taking after the sharp run. Shore Capital Group Reaffirms Hold Rating for Diploma

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.